ReviewCancer pathogenesis and therapy2026

C-X-C chemokine receptor type 4 (CXCR4) antagonism in precision oncology: Clinical applications and future directions.

Aswini Rajendran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.